UPDATE: Deutsche Bank Downgrades Mead Johnson Nutrition to Hold, Reiterates $103 PT Given Current Valuation


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


In a report published Monday, Deutsche Bank analyst Eric Katzman downgraded the rating on

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Mead Johnson Nutrition (NYSE: MJN) from Buy to Hold, but reiterated the $103.00 price target.In the report, Deutsche Bank noted, “With recent headlines pointing to Danone's interest in Mead Johnson as a potential M&A target (Reuters, 10/17/14) and the latter's stock now up close to 20% for 2014, we believe the time is right to downgrade the shares. Given current valuation (25x P/E, 17x EBITDA), we adjust our fundamental-based opinion on Mead to HOLD from BUY, maintaining our $103 target, and removing the stock as our 2014 ‘Top Pick'.”Mead Johnson Nutrition closed on Friday at $100.23.
Posted In: Analyst ColorDowngradesAnalyst RatingsDeutsche BankEric Katzman